Sai Life Sciences Ltd.

•

sailife.comBSE: 544306NSE: SAILIFE

Market Cap₹ 35,579 Cr.

Current Price

High / Low₹ 1,697 / 784

Stock P/E100.4

Book Value₹ 121

Price to Book8.21

Dividend Yield0.00 %

ROCE20.0 %

ROE14.6 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 39.2% CAGR over last 5 years
Company is almost debt free
Company has delivered good sales growth of 23.4% CAGR over last 5 years
Operating margins have improved to 26.7% from 16.8%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.76x)

CONS

Promoter holding has decreased over last 2 years: -3.4pp
Equity base is being diluted - shares outstanding up 20.2%
Stock is trading at 8.2x its book value
Though reporting repeated profits, the company pays out little dividend (0.0%)
Rich enterprise valuation - EV/EBITDA of 31.6x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY PHARMA NIFTY500MOMENTM50 NIFTY SMLCAP 250 NIFTY SMLCAP 50 NIFTY 500

S.No.	Name
1.	SUNPHARMA	1868.50	37.06	448315.74	0.86	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9482.75	86.06	251737.22	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4931.90	86.01	187593.62	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1129.00	24.95	112618.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1368.00	32.79	110515.04	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1933.25	95.54	104455.86	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	AUROPHARMA	1690.00	26.19	97238.86	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
8.	LUPIN	2092.00	17.30	95660.02	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
9.	DRREDDY	1143.20	29.61	95420.61	0.70	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	MANKIND	2266.00	45.82	93596.02	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2439.55	38.29	68850.12	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	SAILIFE	1675.15	98.36	35579.22	0.00	73.28	21.22	554.29	11.66	20.97	26.70

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	373	428	264	382	429	567	483	527	549	594	547
	279	301	240	281	317	413	370	387	370	426	455
Operating Profit	94	127	25	101	111	154	113	140	179	168	92
OPM %	25.10%	29.60%	9.30%	26.38%	25.94%	27.14%	23.39%	26.55%	32.59%	28.29%	16.79%
	11	4	8	10	9	10	10	15	0	16	4
Interest	22	19	20	19	22	9	11	8	8	6	6
Depreciation	28	28	28	33	31	34	34	36	41	41	42
Profit before Tax	54	83	-15	58	68	120	78	111	130	137	95
Tax %	25.78%	26.18%	24.93%	25.05%	24.83%	25.34%	25.15%	25.18%	25.17%	25.08%	25.17%
Net Profit	40	62	-11	44	51	90	58	83	98	103	71
	2.22	3.39	-0.63	2.35	2.74	4.32	2.80	3.97	4.64	4.85	3.36

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	445	526	695	725	751	841	1,157	1,419	1,642	2,153	2,217
	368	426	520	555	587	716	991	1,131	1,250	1,577	1,638
Operating Profit	77	100	175	170	164	125	167	288	392	576	579
OPM %	17.26%	19.00%	25.13%	23.42%	21.85%	14.85%	14.42%	20.30%	23.89%	26.76%	26.11%
	19	7	6	18	27	28	28	29	37	66	35
Interest	12	17	24	21	32	51	74	81	72	34	28
Depreciation	21	27	44	52	72	80	88	107	126	152	160
Profit before Tax	63	62	112	114	88	22	33	129	232	456	474
Tax %	25.35%	32.98%	35.06%	29.75%	25.44%	29.84%	25.85%	26.18%	25.14%	25.14%	25.15%
Net Profit	47	42	73	80	65	16	24	95	173	341	354
EPS	32.72	29.37	51.54	48.95	37.88	8.82	13.29	53.92	8.32	16.12	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 18%
5 Years:: 23%
3 Years:: 23%

COMPOUNDED PROFIT GROWTH

10 Years:: 26%
5 Years:: 39%
3 Years:: 142%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 85%

RETURN ON EQUITY

10 Years:: 10%
5 Years:: 8%
3 Years:: 12%
Last Year:: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	14	14	16	16	17	18	18	18	21	21
	302	346	697	772	843	864	885	983	2,142	2,482
	198	229	288	327	658	880	840	774	236	162
Trade Payables	48	97	108	137	144	193	197	136	333	307
	88	82	103	137	154	151	202	376	466	728
Total Liabilities	651	768	1,212	1,389	1,816	2,106	2,141	2,287	3,197	3,700
	272	307	373	617	702	858	923	1,074	1,378	1,705
Capital Work in Progress	9	14	116	79	192	189	151	107	124	270
	0	0	0	22	63	64	80	80	114	163
	44	73	44	43	73	126	138	86	118	150
	0	0	0	0	0	0	0	259	353	370
Cash & Bank	13	15	247	93	70	124	80	152	458	108
	312	359	431	535	715	747	769	529	652	935
Total Assets	651	768	1,212	1,389	1,816	2,106	2,141	2,287	3,197	3,700

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	38	59	155	128	-9	96	226	251	330	495
Cash from Investing	-69	-62	-158	-259	-279	-95	-111	-190	-565	-393
Cash from Financing	45	12	268	-1	304	81	-190	-85	314	-109
	-6	-1	237	-152	-2	75	-80	-24	80	-7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Mar 2023	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	37.91	35.24	35.24	35.17	35.15	34.94	34.70	34.61	34.53
	0.00	7.63	11.72	12.36	14.57	22.50	21.41	21.17	19.65
	0.00	5.61	11.95	13.26	21.64	29.92	31.41	31.54	32.71
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	56.10	51.52	41.09	39.21	28.64	12.65	12.49	12.68	13.11

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-04 - Sai Life Sciences Limited has informed the Exchange about Schedule of meet

2026-09-04

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-04 - Sai Life Sciences Limited has informed the Exchange about Schedule of meet

2026-09-01

ESOP/ESOS/ESPS

2026-09-01 - Sai Life Sciences Limited has informed the Exchange regarding Allotment of 80600 Shares.

2026-08-26

Copy of Newspaper Publication

2026-08-26 - Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-25

Updates

2026-08-25 - Sai Life Sciences Limited has informed the Exchange regarding 'Web Link Letters to Shareholders'.

2026-08-25

Shareholders meeting

2026-08-25 - Sai Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 17, 2026

2026-08-24

Copy of Newspaper Publication

2026-08-24 - Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-24

Updates

2026-08-24 - Sai Life Sciences Limited has informed the Exchange regarding 'Information relating to 27th Annual General Meeting (AGM) and Cut-off date for e-voting.'.

2026-08-12

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-12 - Sai Life Sciences Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for SAILIFE

Loading news…

🤖

AI Stock Analyst

Sai Life Sciences Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account